About: MediWound Ltd., a biopharmaceutical company, develops, manufactures, and commercializes novel, bio-therapeutic, and non-surgical solutions for tissue repair and regeneration in the United States, Germany, Italy, Spain, and internationally. The company markets NexoBrid, a biopharmaceutical product for the removal of eschar in patients with deep partial- and full-thickness thermal burns to burn centers and hospitals burn units. It also develops EscharEx, a bromelain-based, bioactive enzymatic therapy for the treatment of chronic wounds and other hard-to-heal wounds; and MW005, a topically applied biological product candidate to treat non-melanoma skin cancers. MediWound Ltd. was incorporated in 2000 and is headquartered in Yavne, Israel.
Sector: Healthcare
Industry: Biotechnology
Latest price: $13.86 (+2.21%)
MDWD NASDAQ Mediwound Ltd
Mediwound Ltd share price
Atividade de preço de MDWD
Último preço
$ 13,860
Variação (24h)
0,30 USD (2,21%)
Volume
154.41K
Volume (média 4 sem.)
-
Abertura
$ 13,61
Variação do dia
$ 13,36 - $ 13,97
Fechamento anterior
$ 13,56
Último negócio
29 Oct, 8:00 pm GMT+0
Atrasado
29 Oct, 8:00 pm GMT+0
MDWD price performance
Atrasado
29 Oct, 8:00 pm GMT+0
quote.marketSignals